Development
Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -2.65M | -2.37M | -2.53M | -2.90M | -7.39M |
| Total Depreciation and Amortization | 535.80K | 507.00K | 491.50K | 474.40K | 505.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 279.30K | 320.50K | 415.70K | 639.60K | 4.88M |
| Change in Net Operating Assets | 1.04M | 1.15M | 1.06M | 1.13M | 1.34M |
| Cash from Operations | -794.50K | -389.80K | -556.50K | -654.70K | -667.10K |
| Capital Expenditure | -- | -- | -- | -- | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 900.00 |
| Cash Acquisitions | -- | -- | -- | -- | 1.49M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 1.49M |
| Total Debt Issued | 2.79M | 1.94M | 1.08M | 1.01M | 979.80K |
| Total Debt Repaid | -1.64M | -1.29M | -322.40K | -322.40K | -226.90K |
| Issuance of Common Stock | 27.20K | 27.20K | 6.30K | 151.80K | 288.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 41.10K | 41.10K | -- | -- | -2.22M |
| Cash from Financing | 900.00K | 530.10K | 577.50K | 649.30K | -939.50K |
| Foreign Exchange rate Adjustments | 0.00 | 100.00 | 0.00 | -700.00 | -21.40K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 68.20K |
| Net Change in Cash | 105.40K | 140.30K | 21.00K | -6.00K | -70.80K |